drug development, pharma, industry, biotech

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 

Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.